Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 46
-1
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we use fungi to break down our plastic and rubber waste?

The massive and rapid accumulation of our plastic and rubber waste is a problem that we cannot afford...

Blinded by the light: reducing shearwater deaths along a coastal highway in O'ahu, Hawai'i

Wedge-tailed Shearwater chicks are attracted to lights and grounded due to collisions with utility wires / posts...

Backer Badge Funded